Brown Brothers Harriman & Co’s Abiomed Inc ABMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,514	Closed	-$372K	–	1565
2022 Q3	$372K	Hold	1,514	–	–	﹤0.01%	348
2022 Q2	$375K	Buy	1,514 +14	+0.9%	+$3.78K	﹤0.01%	357
2022 Q1	$497K	Hold	1,500	–	–	﹤0.01%	346
2021 Q4	$539	Hold	1,500	–	–	﹤0.01%	329
2021 Q3	$488	Hold	1,500	–	–	﹤0.01%	330
2021 Q2	$468	Sell	1,500 -13	-0.9%	-$3.99K	﹤0.01%	325
2021 Q1	$482	Buy	1,513 +13	+0.9%	+$4.16K	﹤0.01%	299
2020 Q4	$486K	Hold	1,500	–	–	﹤0.01%	301
2020 Q3	$416K	Hold	1,500	–	–	﹤0.01%	290
2020 Q2	$362K	Hold	1,500	–	–	﹤0.01%	297
2020 Q1	$218K	Hold	1,500	–	–	﹤0.01%	339
2019 Q4	$256K	Sell	1,500 -11	-0.7%	-$2.04K	﹤0.01%	411
2019 Q3	$269K	Buy	1,511 +8	+0.5%	+$1.73K	﹤0.01%	373
2019 Q2	$392K	Buy	1,503 +3	+0.2%	+$796	﹤0.01%	296
2019 Q1	$428K	Sell	1,500 -1,510	-50%	-$502K	﹤0.01%	273
2018 Q4	$978K	Sell	3,010 -5	-0.2%	-$1.74K	0.01%	199
2018 Q3	$1.36M	Hold	3,015	–	–	0.01%	175
2018 Q2	$1.23M	Hold	3,015	–	–	0.01%	170
2018 Q1	$877K	Hold	3,015	–	–	0.01%	196
2017 Q4	$565K	Buy	3,015 +15	+0.5%	+$2.8K	﹤0.01%	231
2017 Q3	$506K	Sell	3,000 -83	-3%	-$12.6K	﹤0.01%	229
2017 Q2	$442K	Hold	3,083	–	–	﹤0.01%	234
2017 Q1	$386K	Hold	3,083	–	–	﹤0.01%	250
2016 Q4	$347K	Hold	3,083	–	–	﹤0.01%	245
2016 Q3	$396K	Hold	3,083	–	–	﹤0.01%	245
2016 Q2	$337K	Buy	3,083 +83	+3%	+$8.26K	﹤0.01%	264
2016 Q1	$284K	Sell	3,000 -500	-14%	-$42.2K	﹤0.01%	276
2015 Q4	$316K	Hold	3,500	–	–	﹤0.01%	277
2015 Q3	$325K	Sell	3,500 -1,500	-30%	-$132K	﹤0.01%	280
2015 Q2	$329K	Hold	5,000	–	–	﹤0.01%	294
2015 Q1	$358K	Hold	5,000	–	–	﹤0.01%	292
2014 Q4	$190K	Hold	5,000	–	–	﹤0.01%	355
2014 Q3	$124K	Hold	5,000	–	–	﹤0.01%	413
2014 Q2	$126K	Hold	5,000	–	–	﹤0.01%	409
2014 Q1	$130K	Hold	5,000	–	–	﹤0.01%	388
2013 Q4	$134K	Hold	5,000	–	–	﹤0.01%	359
2013 Q3	$95K	Buy	5,000 +2,000	+67%	+$45.7K	﹤0.01%	403
2013 Q2	$65K	Buy	+3,000	New	+$60.3K	﹤0.01%	503

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brown Brothers Harriman & Co's ABMD Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,514 shares — an estimated $372K sold.

Brown Brothers Harriman & Co first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $1.36M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Brown Brothers Harriman & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Brown Brothers Harriman & Co sold 1,514 Abiomed Inc shares in Q4 2022, an estimated $372K.
Brown Brothers Harriman & Co first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Brown Brothers Harriman & Co's Abiomed Inc position peaked at $1.36M in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.